Related Experiment Video
Updated: Jul 29, 2026

07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
23.0K
Revolutionizing Neck Rejuvenation: ABO Botulinum Toxin A Solution in Multipoint Technique and NASHA Gel Skinbooster
Journal of Drugs in Dermatology : JDD
|January 11, 2024
Summary
This study presents a non-surgical neck rejuvenation protocol combining ABO Botulinum Toxin A and NASHA gel. The treatment effectively addresses muscle hypertonicity and skin degeneration, offering patients improved skin quality and satisfaction.
Area of Science:
- Aesthetic Medicine
- Dermatology
Background:
- Neck rejuvenation is a popular cosmetic procedure addressing aging concerns.
- Non-surgical options are highly desirable for patients and practitioners.
- This protocol targets muscle hypertonicity and skin degeneration in the neck.
Purpose of the Study:
- To introduce a novel, minimally invasive neck rejuvenation protocol.
- To detail the combined use of ABO Botulinum Toxin A and NASHA gel 12 mg/mL.
- To evaluate the efficacy in improving neck skin quality and muscle tone.
Main Methods:
- Patient selection based on specific criteria.
- Administration of ABO Botulinum Toxin A with tailored dosages and multipoint technique.
- Application of NASHA gel 12 mg/mL skinbooster regimen with precise injection techniques.
Main Results:
- The combined treatment is minimally invasive, cost-effective, and has minimal downtime.
- ABO Botulinum Toxin A demonstrates efficacy in addressing muscle hypertonicity.
- NASHA gel 12 mg/mL consistently enhances skin tone, elasticity, hydration, and radiance.
Conclusions:
- This combined approach offers physicians an effective neck rejuvenation option.
- The protocol enhances patient satisfaction and confidence through gradual, long-lasting improvements.
- It represents an innovative, sought-after treatment in aesthetic medicine.
More Related Videos
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

